A previous study showed that sEVs isolated from bone marrow mesenchymal stem cells successfully delivered anti-miR-142-3p in BC tumors in vivo, restoring the expression levels of their target genes APC and P2X7R, thereby reducing the tumorigenicity of BC in vitro and in vivo (22). This evidence concerns the gene APC and breast cancer.